Honoria Culshaw (1)
PFD Report
All Responded
Ref: 2025-0479
All 1 response received
· Deadline: 19 Nov 2025
Response Status
Responses
1 of 1
56-Day Deadline
19 Nov 2025
All responses received
About PFD responses
Organisations named in PFD reports must respond within 56 days explaining what actions they are taking.
Source: Courts and Tribunals Judiciary
Coroner’s Concerns
Mrs. Culshaw attended Wythenshaw Hospital on the 10th July 2024 an presented with an opening of her pacemaker scar. I heard evidence at the inquest from a Consultant Cardiologist at Wythenshawe that International clinical guidance indicates that any opening of an implantation scar should be interpreted as a sign of systemic infection of the wound and that extraction and replacement of the pacemaker should follow in order to remove the infection. This was the advice of the on-call Cardiologist at Wythenshawe on the 10th July 2024 to the Emergency Department medical team. I heard evidence that Wythenshawe is one a limited number of specialist surgical centres for the extraction of pacemakers.
Mrs. Culshaw was not admitted to Wythenshawe Hospital, but discharged to the care of Royal Preston Hospital, where her pacemaker had been fitted. Royal Preston Hosptial is not a specialist surgical centre for pacemaker extraction. The expectation of Wythenshawe Hosptial at the time of her discharge appears to be that Royal Preston would refer her back to Wythenshawe for extraction. However, the need for extraction and therefore a referral was not communicated by Wythenshawe to either Royal Preston or to Mrs. Culshaw’s GP. It is not clear that it was adequately explained to Mrs. Culshaw’s family.
Mrs. Culshaw re-presented at Wythenshawe on the 9th September, again with signs of infection and underwent an extraction procedure as an inpatient on the 16th September 2024.
However, I found that her experienced of persistent and prolonged infection depleted her physiological reserve and contributed to her succumbing to a fatal pneumonia on the 25th October 2024.
I am concerned that this lack of information sharing along a communication pathway between the Cardiology department and specialist surgical extraction team at Wythenshawe and the Cardiology departments at local treating hospitals risks such referrals being delayed or not being made at all, as happened in the present case.
Mrs. Culshaw was not admitted to Wythenshawe Hospital, but discharged to the care of Royal Preston Hospital, where her pacemaker had been fitted. Royal Preston Hosptial is not a specialist surgical centre for pacemaker extraction. The expectation of Wythenshawe Hosptial at the time of her discharge appears to be that Royal Preston would refer her back to Wythenshawe for extraction. However, the need for extraction and therefore a referral was not communicated by Wythenshawe to either Royal Preston or to Mrs. Culshaw’s GP. It is not clear that it was adequately explained to Mrs. Culshaw’s family.
Mrs. Culshaw re-presented at Wythenshawe on the 9th September, again with signs of infection and underwent an extraction procedure as an inpatient on the 16th September 2024.
However, I found that her experienced of persistent and prolonged infection depleted her physiological reserve and contributed to her succumbing to a fatal pneumonia on the 25th October 2024.
I am concerned that this lack of information sharing along a communication pathway between the Cardiology department and specialist surgical extraction team at Wythenshawe and the Cardiology departments at local treating hospitals risks such referrals being delayed or not being made at all, as happened in the present case.
Responses
Manchester University NHS Foundation Trust is currently implementing new processes within its electronic patient record (HIVE) to allow discharge letters to be sent to additional healthcare providers. An education programme will be facilitated for cardiology staff by December 2025, and relevant training incorporated into induction for new residents starting February 2026.
AI summary
View full response
Dear Ms Morris
The late Mrs Honoria Culshaw – 11 June 1958 – 28 October 2024 Response to Prevention of Future Deaths Report
I am grateful to you for providing us with the opportunity to respond to the concerns which arose during the Inquest into the death of the late Honoria Culshaw, namely “[a] lack for information sharing along a communication pathway between the cardiology department at Wythenshawe and the cardiology departments at local treating hospitals risks such referrals being delayed or not being made at all.”
The team at Manchester University NHS Foundation Trust (‘the Trust’) would like to reiterate our condolences to the family of Mrs Culshaw on their loss.
Actions taken by Manchester University NHS Foundation Trust The introduction in September 2022 of HIVE, the new electronic patient record at Manchester University NHS Foundation Trust, offered the chance for the Trust to develop new processes for communication across health providers, as can often be the case.
Mrs Culshaw was discharged from the Emergency Department at Wythenshawe Hospital on 10 July 2024 following advice from the Cardiology registrar on call concerning her implanted medical device. This advice for further action of referring Mrs Culshaw to Preston Cardiology was documented on the discharge letter and sent to Mrs Culshaw’s general practitioner to action in line with Trust policies in place at that time.
In the UK, discharge letters are traditionally only sent to a patient’s general practitioner. It is possible in the Trust’s electronic patient record system’s (HIVE) functionality to send copies of the discharge summary to additional recipients as well as the general practitioner. This functionality is available in all workflows including those used by the Emergency Department and Cardiology.
A10
Onward communication and referral to external providers have been a key area of focus and improvement for the Trust. Following this case, further work is being done with discharge communications from Emergency Departments to provide structured discharge information and also built in reminders to staff that if a referral is required, the correct process is following at the point of discharge. This includes working with digital colleagues to review the practicalities of amending the current Emergency Department notes that are generated by the Trust.
As part of the rolling programme of improvements of the use of HIVE, the Trust is committed to improve the discharge process in our Emergency Departments to ensure that the workflow is seamless and our clinical teams are aware of the functionality to send copies of Emergency Department discharge letters to a full range of healthcare providers. This would include cardiology departments at providers such as the Royal Preston Hospital.
In keeping with a system approach to patient safety, the Trust is looking to make the process as simple as possible for clinical teams by making workflows seamless and intuitive, and supporting staff training and induction in relation to the discharge processes.
The Trust will also develop additional HIVE tip sheets and video guides to increase knowledge and awareness of the ‘correspondence’ tab in the Emergency Department’s discharge navigator within HIVE. The tip sheets and video guides will be availably by 15 December 2025 and shared with all relevant staff members by this date by the Emergency Department’s Clinical Head of Division.
Once the tip sheets and video guides are available, Emergency Department discharge processes will be incorporated into the normal weekly Resident training sessions and as part of Residents’ Trust Induction. This training will include a topic on communicating with healthcare professionals other than the patient’s general practitioner when it is relevant to do so. The target date for this reaching all current Emergency Department Resident staff at the Trust is 31 January 2026.
This training will be incorporated into Emergency Department Residents’ Induction training in time for the next cohort starting in February 2026. The Emergency Department Trust Specialty Training Lead (TSTL) will amend and update the Induction training package accordingly.
The intention is that the ‘correspondence’ workflow will appear in the ‘Dispo’ section (the discharge navigator for the Emergency Department). This will require a fundamental HIVE build and therefore will not be completed until June 2026.
We have reinforced with the Cardiology Department that communication with other secondary and tertiary care providers is of paramount importance to ensure continuity of care is maximised for patients. From 15 December 2025 onwards when the tip sheets and video guides are available, Cardiology Residents’ training will include focused education regarding the processes available to copy inpatient discharge letters that are sent to general practitioners to other relevant healthcare providers. This uses the same process within the electronic patient record as medical staff use to send letters following outpatient clinic appointments. This training will be A11
incorporated into Cardiology Residents’ Induction training in time for the next cohort starting in February 2026. The Cardiology Trust Specialty Training Lead (TSTL) will amend and update the Induction training package accordingly. The tip sheets and video guides will be shared with all relevant staff members by 15 December 2025 by the Cardiology Clinical Head of Division.
Furthermore, these tip sheets and video guides will ensure that the on-call Cardiology teams are aware of the Permanent Pacemaker Extraction services that are available at Wythenshawe and the indications for referral and how to generate a referral. This will also be covered in the Induction training.
The Associate Medical Director for Quality and Patient Safety will also share the tip sheets and video guides with all the Medical and Nursing Directors across the Trust for more widespread distribution. This will be completed by 15 December 2025.
I trust that this reply has assured you that Manchester University NHS Foundation Trust has taken your concerns seriously and have learned from the events which contributed to Mrs Culshaw’s death.
On behalf of the Trust, I would like once again to offer Mrs Culshaw’s family condolences on their loss.
The late Mrs Honoria Culshaw – 11 June 1958 – 28 October 2024 Response to Prevention of Future Deaths Report
I am grateful to you for providing us with the opportunity to respond to the concerns which arose during the Inquest into the death of the late Honoria Culshaw, namely “[a] lack for information sharing along a communication pathway between the cardiology department at Wythenshawe and the cardiology departments at local treating hospitals risks such referrals being delayed or not being made at all.”
The team at Manchester University NHS Foundation Trust (‘the Trust’) would like to reiterate our condolences to the family of Mrs Culshaw on their loss.
Actions taken by Manchester University NHS Foundation Trust The introduction in September 2022 of HIVE, the new electronic patient record at Manchester University NHS Foundation Trust, offered the chance for the Trust to develop new processes for communication across health providers, as can often be the case.
Mrs Culshaw was discharged from the Emergency Department at Wythenshawe Hospital on 10 July 2024 following advice from the Cardiology registrar on call concerning her implanted medical device. This advice for further action of referring Mrs Culshaw to Preston Cardiology was documented on the discharge letter and sent to Mrs Culshaw’s general practitioner to action in line with Trust policies in place at that time.
In the UK, discharge letters are traditionally only sent to a patient’s general practitioner. It is possible in the Trust’s electronic patient record system’s (HIVE) functionality to send copies of the discharge summary to additional recipients as well as the general practitioner. This functionality is available in all workflows including those used by the Emergency Department and Cardiology.
A10
Onward communication and referral to external providers have been a key area of focus and improvement for the Trust. Following this case, further work is being done with discharge communications from Emergency Departments to provide structured discharge information and also built in reminders to staff that if a referral is required, the correct process is following at the point of discharge. This includes working with digital colleagues to review the practicalities of amending the current Emergency Department notes that are generated by the Trust.
As part of the rolling programme of improvements of the use of HIVE, the Trust is committed to improve the discharge process in our Emergency Departments to ensure that the workflow is seamless and our clinical teams are aware of the functionality to send copies of Emergency Department discharge letters to a full range of healthcare providers. This would include cardiology departments at providers such as the Royal Preston Hospital.
In keeping with a system approach to patient safety, the Trust is looking to make the process as simple as possible for clinical teams by making workflows seamless and intuitive, and supporting staff training and induction in relation to the discharge processes.
The Trust will also develop additional HIVE tip sheets and video guides to increase knowledge and awareness of the ‘correspondence’ tab in the Emergency Department’s discharge navigator within HIVE. The tip sheets and video guides will be availably by 15 December 2025 and shared with all relevant staff members by this date by the Emergency Department’s Clinical Head of Division.
Once the tip sheets and video guides are available, Emergency Department discharge processes will be incorporated into the normal weekly Resident training sessions and as part of Residents’ Trust Induction. This training will include a topic on communicating with healthcare professionals other than the patient’s general practitioner when it is relevant to do so. The target date for this reaching all current Emergency Department Resident staff at the Trust is 31 January 2026.
This training will be incorporated into Emergency Department Residents’ Induction training in time for the next cohort starting in February 2026. The Emergency Department Trust Specialty Training Lead (TSTL) will amend and update the Induction training package accordingly.
The intention is that the ‘correspondence’ workflow will appear in the ‘Dispo’ section (the discharge navigator for the Emergency Department). This will require a fundamental HIVE build and therefore will not be completed until June 2026.
We have reinforced with the Cardiology Department that communication with other secondary and tertiary care providers is of paramount importance to ensure continuity of care is maximised for patients. From 15 December 2025 onwards when the tip sheets and video guides are available, Cardiology Residents’ training will include focused education regarding the processes available to copy inpatient discharge letters that are sent to general practitioners to other relevant healthcare providers. This uses the same process within the electronic patient record as medical staff use to send letters following outpatient clinic appointments. This training will be A11
incorporated into Cardiology Residents’ Induction training in time for the next cohort starting in February 2026. The Cardiology Trust Specialty Training Lead (TSTL) will amend and update the Induction training package accordingly. The tip sheets and video guides will be shared with all relevant staff members by 15 December 2025 by the Cardiology Clinical Head of Division.
Furthermore, these tip sheets and video guides will ensure that the on-call Cardiology teams are aware of the Permanent Pacemaker Extraction services that are available at Wythenshawe and the indications for referral and how to generate a referral. This will also be covered in the Induction training.
The Associate Medical Director for Quality and Patient Safety will also share the tip sheets and video guides with all the Medical and Nursing Directors across the Trust for more widespread distribution. This will be completed by 15 December 2025.
I trust that this reply has assured you that Manchester University NHS Foundation Trust has taken your concerns seriously and have learned from the events which contributed to Mrs Culshaw’s death.
On behalf of the Trust, I would like once again to offer Mrs Culshaw’s family condolences on their loss.
Report Sections
Investigation and Inquest
On the 19th December 2024, I commenced an investigation into the death of Honoria Culshaw. On the 11th September 2025 I heard the inquest touching on her death. On that date I returned a narrative conclusion as follows:
The deceased died from pneumonia which she developed following treatment for sepsis which originated from an infected pacemaker site. Her underlying cardiac and immunological conditions contributed to her deterioration following necessary surgery on the 16th September 2024 to extract her pacemaker and made it more likely that she would contract a fatal pneumonia. At the Inquest on the 11th September 2025 I made the following findings:
I found that the Mrs. Culshaw had a pacemaker fitted in 2013 to support her heart function.
In November 2023 the pacemaker’s batteries were replaced in a surgical procedure. In March 2024 the deceased presented to her GP with signs of infection at the site of the surgical wound. In July 2024 the deceased presented to Wythenshawe Hospital with opening of her wound. This was likely evidence of a systemic infection arising from the pacemaker site and guidance indicates that consideration should have been given to extracting and replacing the pacemaker to remove the infection. She was advised to attend Royal Preston Hospital, her pacemaker care centre. At the Royal Preston Hospital, a decision was made to manage the wound conservatively by re-siting the pacemaker box and prescribing anti-biotics. On the 15th August 2024 a swab came back positive for Morganella Morganii bacteria. It is not clear on the evidence who on the clinical team was aware of these results before the deceased underwent surgery on the 20th August to reposition her pacemaker. She was prescribed anti-biotics in any event that would have been appropriate to treat this particular bacteria. She was seen by a Consultant Cardiologist on the 3rd September 2024 who observed that the wound was healing and there were no clinical signs of infection.
On the 9th September 2024, the Mrs. Culshaw presented again at Wythenshawe with further deterioration of her pacemaker wound and sepsis. She underwent an extraction procedure on the 16th September 2024 to remove the pacemaker and prescribed antibiotics. She completed the course of anti-biotics, but then developed a widespread acute rash, which was probably a reaction to the anti-biotics. She was also found to have suffered a pulmonary embolus, a known complication of pacemaker extraction surgery.
Despite appropriate post-surgical interventions and treatment, the deceased’s condition began to deteriorate around the 10th October 2024. I find that the deceased’s exposure to repeated and persistent infections and sepsis, together with the physiological trauma of necessary surgery for pacemaker extraction and her inflammatory reaction to appropriate anti-biotic treatment is likely to have placed an unsustainable load on her cardio-respiratory system. The deceased’s physiological reserves were depleted by her chronic Idiopathic Thrombocytopenic Purpura and her underlying heart conditions. The deceased was placed on a palliative care pathway and discharged to her own home, where she died on the 25th October 2024. On the basis of the pathological evidence, I find that following her discharge, the deceased developed a pneumonia, in light of her co-morbidities and recent medical interventions, was fatal.
The deceased died from pneumonia which she developed following treatment for sepsis which originated from an infected pacemaker site. Her underlying cardiac and immunological conditions contributed to her deterioration following necessary surgery on the 16th September 2024 to extract her pacemaker and made it more likely that she would contract a fatal pneumonia. At the Inquest on the 11th September 2025 I made the following findings:
I found that the Mrs. Culshaw had a pacemaker fitted in 2013 to support her heart function.
In November 2023 the pacemaker’s batteries were replaced in a surgical procedure. In March 2024 the deceased presented to her GP with signs of infection at the site of the surgical wound. In July 2024 the deceased presented to Wythenshawe Hospital with opening of her wound. This was likely evidence of a systemic infection arising from the pacemaker site and guidance indicates that consideration should have been given to extracting and replacing the pacemaker to remove the infection. She was advised to attend Royal Preston Hospital, her pacemaker care centre. At the Royal Preston Hospital, a decision was made to manage the wound conservatively by re-siting the pacemaker box and prescribing anti-biotics. On the 15th August 2024 a swab came back positive for Morganella Morganii bacteria. It is not clear on the evidence who on the clinical team was aware of these results before the deceased underwent surgery on the 20th August to reposition her pacemaker. She was prescribed anti-biotics in any event that would have been appropriate to treat this particular bacteria. She was seen by a Consultant Cardiologist on the 3rd September 2024 who observed that the wound was healing and there were no clinical signs of infection.
On the 9th September 2024, the Mrs. Culshaw presented again at Wythenshawe with further deterioration of her pacemaker wound and sepsis. She underwent an extraction procedure on the 16th September 2024 to remove the pacemaker and prescribed antibiotics. She completed the course of anti-biotics, but then developed a widespread acute rash, which was probably a reaction to the anti-biotics. She was also found to have suffered a pulmonary embolus, a known complication of pacemaker extraction surgery.
Despite appropriate post-surgical interventions and treatment, the deceased’s condition began to deteriorate around the 10th October 2024. I find that the deceased’s exposure to repeated and persistent infections and sepsis, together with the physiological trauma of necessary surgery for pacemaker extraction and her inflammatory reaction to appropriate anti-biotic treatment is likely to have placed an unsustainable load on her cardio-respiratory system. The deceased’s physiological reserves were depleted by her chronic Idiopathic Thrombocytopenic Purpura and her underlying heart conditions. The deceased was placed on a palliative care pathway and discharged to her own home, where she died on the 25th October 2024. On the basis of the pathological evidence, I find that following her discharge, the deceased developed a pneumonia, in light of her co-morbidities and recent medical interventions, was fatal.
Copies Sent To
2. Royal Preston Hospital
Lancashire Teaching Hospitals Foundation Trust
Inquest Conclusion
The deceased died from pneumonia which she developed following treatment for sepsis which originated from an infected pacemaker site. Her underlying cardiac and immunological conditions contributed to her deterioration following necessary surgery on the 16th September 2024 to extract her pacemaker and made it more likely that she would contract a fatal pneumonia. At the Inquest on the 11th September 2025 I made the following findings:
I found that the Mrs. Culshaw had a pacemaker fitted in 2013 to support her heart function.
In November 2023 the pacemaker’s batteries were replaced in a surgical procedure. In March 2024 the deceased presented to her GP with signs of infection at the site of the surgical wound. In July 2024 the deceased presented to Wythenshawe Hospital with opening of her wound. This was likely evidence of a systemic infection arising from the pacemaker site and guidance indicates that consideration should have been given to extracting and replacing the pacemaker to remove the infection. She was advised to attend Royal Preston Hospital, her pacemaker care centre. At the Royal Preston Hospital, a decision was made to manage the wound conservatively by re-siting the pacemaker box and prescribing anti-biotics. On the 15th August 2024 a swab came back positive for Morganella Morganii bacteria. It is not clear on the evidence who on the clinical team was aware of these results before the deceased underwent surgery on the 20th August to reposition her pacemaker. She was prescribed anti-biotics in any event that would have been appropriate to treat this particular bacteria. She was seen by a Consultant Cardiologist on the 3rd September 2024 who observed that the wound was healing and there were no clinical signs of infection.
On the 9th September 2024, the Mrs. Culshaw presented again at Wythenshawe with further deterioration of her pacemaker wound and sepsis. She underwent an extraction procedure on the 16th September 2024 to remove the pacemaker and prescribed antibiotics. She completed the course of anti-biotics, but then developed a widespread acute rash, which was probably a reaction to the anti-biotics. She was also found to have suffered a pulmonary embolus, a known complication of pacemaker extraction surgery.
Despite appropriate post-surgical interventions and treatment, the deceased’s condition began to deteriorate around the 10th October 2024. I find that the deceased’s exposure to repeated and persistent infections and sepsis, together with the physiological trauma of necessary surgery for pacemaker extraction and her inflammatory reaction to appropriate anti-biotic treatment is likely to have placed an unsustainable load on her cardio-respiratory system. The deceased’s physiological reserves were depleted by her chronic Idiopathic Thrombocytopenic Purpura and her underlying heart conditions. The deceased was placed on a palliative care pathway and discharged to her own home, where she died on the 25th October 2024. On the basis of the pathological evidence, I find that following her discharge, the deceased developed a pneumonia, in light of her co-morbidities and recent medical interventions, was fatal.
I found that the Mrs. Culshaw had a pacemaker fitted in 2013 to support her heart function.
In November 2023 the pacemaker’s batteries were replaced in a surgical procedure. In March 2024 the deceased presented to her GP with signs of infection at the site of the surgical wound. In July 2024 the deceased presented to Wythenshawe Hospital with opening of her wound. This was likely evidence of a systemic infection arising from the pacemaker site and guidance indicates that consideration should have been given to extracting and replacing the pacemaker to remove the infection. She was advised to attend Royal Preston Hospital, her pacemaker care centre. At the Royal Preston Hospital, a decision was made to manage the wound conservatively by re-siting the pacemaker box and prescribing anti-biotics. On the 15th August 2024 a swab came back positive for Morganella Morganii bacteria. It is not clear on the evidence who on the clinical team was aware of these results before the deceased underwent surgery on the 20th August to reposition her pacemaker. She was prescribed anti-biotics in any event that would have been appropriate to treat this particular bacteria. She was seen by a Consultant Cardiologist on the 3rd September 2024 who observed that the wound was healing and there were no clinical signs of infection.
On the 9th September 2024, the Mrs. Culshaw presented again at Wythenshawe with further deterioration of her pacemaker wound and sepsis. She underwent an extraction procedure on the 16th September 2024 to remove the pacemaker and prescribed antibiotics. She completed the course of anti-biotics, but then developed a widespread acute rash, which was probably a reaction to the anti-biotics. She was also found to have suffered a pulmonary embolus, a known complication of pacemaker extraction surgery.
Despite appropriate post-surgical interventions and treatment, the deceased’s condition began to deteriorate around the 10th October 2024. I find that the deceased’s exposure to repeated and persistent infections and sepsis, together with the physiological trauma of necessary surgery for pacemaker extraction and her inflammatory reaction to appropriate anti-biotic treatment is likely to have placed an unsustainable load on her cardio-respiratory system. The deceased’s physiological reserves were depleted by her chronic Idiopathic Thrombocytopenic Purpura and her underlying heart conditions. The deceased was placed on a palliative care pathway and discharged to her own home, where she died on the 25th October 2024. On the basis of the pathological evidence, I find that following her discharge, the deceased developed a pneumonia, in light of her co-morbidities and recent medical interventions, was fatal.
Similar PFD Reports
Reports sharing organisations, categories, or themes with this PFD
Related Inquiry Recommendations
Public inquiry recommendations addressing similar themes
Data sourced from Courts and Tribunals Judiciary under the Open Government Licence.